Fred Hutchinson Cancer Center
This clinical trial evaluates a palliative care consultation for improving communication between providers and patients considering surgery for a pancreatic neoplasm. Pancreatic operations have known complications that can affect quality of life. Palliative care has been shown to improve patient reported quality of life and functional outcomes. Receiving a palliative care consultation may improve communication and decision making for patients considering surgery for a pancreatic neoplasm.
Pancreatic Neoplasm
Best Practice
Palliative Care Consultation
Survey Administration
Tumor Board Review
NA
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive usual care and undergo evaluation by a tumor board within 14 days of baseline. ARM II: Patients attend a palliative care visit over 60 minutes to discuss their illness, quality of life, fears and concerns and communication preferences within 7 days of baseline. Patients also undergo evaluation by a tumor board within 14 days of baseline. After completion of study intervention, patients are followed up 7 days after the tumor board visit and 90 days after initiation of treatment.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 40 participants |
Masking : | NONE |
Primary Purpose : | SUPPORTIVE_CARE |
Official Title : | Preoperative, Specialty Palliative Care for Patients Considering Pancreatic Surgery: Pilot Feasibility and Acceptability Study |
Actual Study Start Date : | 2025-05-01 |
Estimated Primary Completion Date : | 2026-01-01 |
Estimated Study Completion Date : | 2026-01-01 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109